DrugsOncology Daratumumab A Targeted Therapy for Hematologic Malignancies Admin October 31, 2024 Daratumumab, a monoclonal antibody, has revolutionized the treatment landscape for hematologic malignancies. It targets CD38, a protein expressed on the surface of multiple myeloma and